⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17754508 | 0.87 | — | — | |
| SCHEMBL17576649 | 0.81 | — | — | |
| SCHEMBL20329178 | 0.81 | — | — | |
| SCHEMBL24098480 | 0.80 | FGF1 (0.30) | — | |
| SCHEMBL10020490 | 0.80 | FGF1 (0.30) | — | |
| SCHEMBL15149899 | 0.80 | FGF1 (0.30) | — | |
| SCHEMBL22326512 | 0.79 | — | — | |
| SCHEMBL20334696 | 0.78 | — | — | |
| SCHEMBL21687065 | 0.76 | — | — | |
| SCHEMBL17754502 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180179542-A1 | OLIGONUCLEOTIDE TARGETING STRATEGY FOR cccDNA | ALIOS BIOPHARMA, INC. (US) | 2018-06-28 | — | — | US | disclosed |